Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Novak

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|April 21, 2023
Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-upLaura Aponte Becerra, Anna Gavrieli, Faizan Khan, et al.
Journal of Neurology|October 13, 2016
Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalitiesFreddy J Alfaro, Vasileios-Arsenios Lioutas, Daniela A Pimentel, et al.
Diabetes Care|September 20, 2011
Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetesVera Novak, Peng Zhao, Brad Manor, et al.
Cerebellum (London, England)|April 30, 2013
Cerebellar TMS in treatment of a patient with cerebellar ataxia: evidence from clinical, biomechanics and neurophysiological assessmentsFaranak Farzan, Yunfen Wu, Brad Manor, et al.
Stroke|October 26, 2018
Dynamic Cerebral Autoregulation Is an Independent Functional Outcome Predictor of Mild Acute Ischemic StrokeNai-Fang Chi, Han-Hwa Hu, Cheng-Yen Wang, et al.
Diabetes Care|June 28, 2006
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetesVera Novak, David Last, David C Alsop, et al.
Diabetes Care|October 9, 2013
Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetesVera Novak, William Milberg, Ying Hao, et al.
Diabetes Care|February 10, 2007
Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivityDavid Last, David C Alsop, Amir M Abduljalil, et al.
Journal of Neurology|August 1, 2018
Lower cerebral vasoreactivity as a predictor of gait speed decline in type 2 diabetes mellitusChen-Chih Chung, Daniela A Pimentel Maldonado, Azizah J Jor'dan, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2011
Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's diseaseSaara M Rissanen, Markku Kankaanpää, Mika P Tarvainen, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Clinical Nutrition (Edinburgh, Scotland)|April 21, 2023
Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-upLaura Aponte Becerra, Anna Gavrieli, Faizan Khan, et al.
Journal of Neurology|October 13, 2016
Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalitiesFreddy J Alfaro, Vasileios-Arsenios Lioutas, Daniela A Pimentel, et al.
Diabetes Care|September 20, 2011
Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetesVera Novak, Peng Zhao, Brad Manor, et al.
Cerebellum (London, England)|April 30, 2013
Cerebellar TMS in treatment of a patient with cerebellar ataxia: evidence from clinical, biomechanics and neurophysiological assessmentsFaranak Farzan, Yunfen Wu, Brad Manor, et al.
Stroke|October 26, 2018
Dynamic Cerebral Autoregulation Is an Independent Functional Outcome Predictor of Mild Acute Ischemic StrokeNai-Fang Chi, Han-Hwa Hu, Cheng-Yen Wang, et al.
Diabetes Care|June 28, 2006
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetesVera Novak, David Last, David C Alsop, et al.
Diabetes Care|October 9, 2013
Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetesVera Novak, William Milberg, Ying Hao, et al.
Diabetes Care|February 10, 2007
Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivityDavid Last, David C Alsop, Amir M Abduljalil, et al.
Journal of Neurology|August 1, 2018
Lower cerebral vasoreactivity as a predictor of gait speed decline in type 2 diabetes mellitusChen-Chih Chung, Daniela A Pimentel Maldonado, Azizah J Jor'dan, et al.
IEEE Transactions on Bio-Medical Engineering|June 16, 2011
Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's diseaseSaara M Rissanen, Markku Kankaanpää, Mika P Tarvainen, et al.
Pageof 10